ARCHIVES

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 1 | January 25, 2008

Download PDF Visit The Full Archive

Related Articles

Money Earmarked for WVU Center Could Be Returned To Treasury; BYRD Get Assurances From DeVita

May 31, 1985

Paul Marks To Chair Search Committee For NCI Director

January 20, 1995

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

May 23, 2003

ACR Presses Effort to Demonstrate Radiotherapy Is As Good As Or Better Than Surgery

October 2, 1981

One In 8 Survivors Report Suicidal Thoughts, Attempts

August 25, 2006

ASC Survey Leads to Strategic Plan Development, Office In Washington

June 9, 1989